Sinohealth Holdings Limited
Informe acción SEHK:2361
Capitalización de mercado: HK$1.9b
Sinohealth Holdings Crecimiento futuro
Future controles de criterios 2/6 Se prevé un crecimiento anual de los beneficios y los ingresos de Sinohealth Holdings de 9.9% y 11.7% por año respectivamente. Se prevé que el BPA crezca en un 9.6% al año. Se espera que la rentabilidad financiera sea de 11.3% en 3 años.
Información clave
9.9%
Tasa de crecimiento de los beneficios
9.6%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Healthcare Services 36.4% Tasa de crecimiento de los ingresos 11.7% Rentabilidad financiera futura 11.3% Cobertura de analistas Low
Última actualización 29 Aug 2024
Actualizaciones recientes sobre el crecimiento futuro
Mostrar todas las actualizaciones
Sinohealth Holdings' (HKG:2361) Anemic Earnings Might Be Worse Than You Think Sep 30
Sinohealth Holdings Limited Announces Resignation of Wan Chuan as Joint Company Secretary Sep 10
First half 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.11 in 1H 2023) Sep 02
Consensus EPS estimates fall by 14% Aug 29
Sinohealth Holdings Limited to Report First Half, 2024 Results on Aug 28, 2024 Aug 16
Sinohealth Holdings Limited Declares Final Dividend for the Year Ended December 31, 2023 Jun 19
Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Apr 27
Sinohealth Holdings Limited, Annual General Meeting, Jun 19, 2024 Mar 30 Sinohealth Holdings Limited, Annual General Meeting, Jun 19, 2024
Sinohealth Holdings Limited to Report Fiscal Year 2023 Results on Mar 28, 2024 Mar 19
Investor sentiment improves as stock rises 19% Dec 26
Consensus revenue estimates decrease by 11%, EPS upgraded Sep 01
First half 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.01 in 1H 2022) Aug 28
New major risk - Revenue and earnings growth Aug 26
Sinohealth Holdings Limited to Report Q2, 2023 Results on Aug 25, 2023 Aug 16
Investor sentiment improves as stock rises 21% Jun 30
Sinohealth Holdings Limited Declares Final Dividend for the Year Ended 31 December 2022 Jun 20
Weak Statutory Earnings May Not Tell The Whole Story For Sinohealth Holdings (HKG:2361) Apr 28
Investor sentiment improves as stock rises 16% Apr 28
Sinohealth Holdings Limited Just Recorded A 240% EPS Beat: Here's What Analysts Are Forecasting Next Apr 02
Full year 2022 earnings: EPS and revenues exceed analyst expectations Mar 31
Investor sentiment improves as stock rises 16% Feb 27
Investor sentiment improved over the past week Dec 06
Investor sentiment deteriorated over the past week Nov 21
High number of new and inexperienced directors Nov 16
Investor sentiment deteriorated over the past week Oct 28
Investor sentiment improved over the past week Sep 23
First half 2022 earnings released Sep 03
Investor sentiment deteriorated over the past week Aug 31
Sinohealth Holdings Limited to Report First Half, 2022 Results on Aug 29, 2022 Aug 18
Sinohealth Holdings Limited has completed an IPO in the amount of HKD 402 million. Jul 12
Insufficient new directors Jul 12
Previsiones de crecimiento de beneficios e ingresos SEHK:2361 - Estimaciones futuras de los analistas y datos financieros pasados (CNY Millions) Fecha Ingresos Beneficios Flujo de caja libre Flujo de caja operativo Núm. de analistas medio 12/31/2026 585 115 N/A 108 1 12/31/2025 525 102 N/A 91 1 12/31/2024 438 78 N/A 75 1 6/30/2024 411 96 49 51 N/A 3/31/2024 403 99 62 65 N/A 12/31/2023 396 102 76 79 N/A 9/30/2023 388 101 75 79 N/A 6/30/2023 380 100 74 78 N/A 3/31/2023 369 78 51 55 N/A 12/31/2022 357 56 28 33 N/A 9/30/2022 348 61 24 28 N/A 6/30/2022 338 66 20 23 N/A 3/31/2022 331 72 39 41 N/A 12/31/2021 324 79 57 60 N/A 12/31/2020 202 68 60 62 N/A 12/31/2019 178 56 53 58 N/A
Mostrar más
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (9.9% al año) de 2361 es superior a la tasa de ahorro (2.3%).
Beneficios vs. Mercado: Se prevé que los beneficios (9.9% al año) de 2361 crezcan menos que el mercado Hong Kong (11.8% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de 2361 crezcan, pero no significativamente .
Ingresos vs. Mercado: Se prevé que los ingresos (11.7% al año) de 2361 crezcan más rápidamente que los del mercado Hong Kong (7.8% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 11.7% al año) de 2361 crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de 2361 sea baja dentro de 3 años (11.3%).
Descubre empresas en crecimiento Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}